Breast cancer progression is affected by multiple factors, including but not limited to subtypes (estrogen receptor [ER], progesterone receptor3, and human epidermal growth factor receptor 2 [HER2] status), grade, and stages. This evidence concerns the gene ESR1 and breast carcinoma.